Corporate Leniency Should Come With A Warning Label
May 22, 2013, 2:42 PM EDT
Law360, New York (May 22, 2013, 2:42 PM EDT) -- When a doctor discovers a patient has a life-threatening condition there is often a good news/bad news discussion. The good news is that there is a treatment; the bad news is that the side effects may be fatal. When a client comes to the antitrust doctor with a case of “cartelitis" the discussion of treatment options can run much along the same lines.
The benefits of the corporate leniency “cure” are well known. While the Antitrust Division [“Division”] does not have an advertisement featuring a successful...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.